Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari

Bari, Apulia 70124

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia

Studies at this site

• A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed